Thomas, S.D.; Jayaprakash, P.; Marwan, N.Z.H.J.; Aziz, E.A.B.A.; Kuder, K.; Łażewska, D.; Kieć-Kononowicz, K.; Sadek, B.
Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice. Pharmaceuticals 2024, 17, 1293.
https://doi.org/10.3390/ph17101293
AMA Style
Thomas SD, Jayaprakash P, Marwan NZHJ, Aziz EABA, Kuder K, Łażewska D, Kieć-Kononowicz K, Sadek B.
Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice. Pharmaceuticals. 2024; 17(10):1293.
https://doi.org/10.3390/ph17101293
Chicago/Turabian Style
Thomas, Shilu Deepa, Petrilla Jayaprakash, Nurfirzana Z. H. J. Marwan, Ezzatul A. B. A. Aziz, Kamil Kuder, Dorota Łażewska, Katarzyna Kieć-Kononowicz, and Bassem Sadek.
2024. "Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice" Pharmaceuticals 17, no. 10: 1293.
https://doi.org/10.3390/ph17101293
APA Style
Thomas, S. D., Jayaprakash, P., Marwan, N. Z. H. J., Aziz, E. A. B. A., Kuder, K., Łażewska, D., Kieć-Kononowicz, K., & Sadek, B.
(2024). Alleviation of Autophagic Deficits and Neuroinflammation by Histamine H3 Receptor Antagonist E159 Ameliorates Autism-Related Behaviors in BTBR Mice. Pharmaceuticals, 17(10), 1293.
https://doi.org/10.3390/ph17101293